PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Profound Medical Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$5.86−0.15 (-2.50%)
Close on Oct 19, 2026
- Market cap
- $213.01M
- P/E (TTM)
- 4.2
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
45.2%
16M of 37M shares
Institutional holders
56
5 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Neil Gagnon | 3,346,743 | 11.20% | 13G (passive) amendment | Dec 31, 2024 |
| FIL Limited | 1,200,635 | 5.62% | 13G (passive) amendment | Feb 9, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PROF | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FIL Ltd | 2,370,000 | 6.49% | $15.76M | +30,000 | 0.01% |
| Gagnon Securities LLC | 1,960,074 | 5.37% | $13.03M | +15,750 | 2.51% |
| Royce & Associates LP | 1,199,564 | 3.28% | $7.98M | +83,216 | 0.06% |
| Timelo Investment Management Inc. | 1,114,967 | 3.05% | $7.41M | – | 2.13% |
| Gagnon Advisors, LLC | 962,186 | 2.63% | $6.40M | – | 4.07% |
| Letko, Brosseau & Associates Inc | 935,725 | 2.56% | $5.40M | −17,450 | 0.08% |
| First Eagle Investment Management, LLC | 880,414 | 2.41% | $5.85M | +557,707 | 0.00% |
| Rosalind Advisors, Inc. | 828,118 | 2.27% | $5.51M | – | 2.05% |
| Z3 Capital Partners, LLC | 820,941 | 2.25% | $5.46M | +2,950 | 1.15% |
| MMCAP International Inc. SPC | 671,356 | 1.84% | $4.46M | −73,796 | 0.38% |
| Ardsley Advisory Partners LP | 575,000 | 1.57% | $3.82M | – | 0.40% |
| Ring Mountain Capital, LLC | 511,917 | 1.40% | $3.40M | +812 | 1428.53% |
| Lagoda Investment Management, L.P. | 501,325 | 1.37% | $3.33M | +60,310 | 1.83% |
| Royal Bank of Canada | 491,495 | 1.35% | $3.27M | −1,565 | 0.00% |
| DAFNA Capital Management LLC | 260,360 | 0.71% | $1.73M | −2,645 | 0.33% |
| Bleichroeder LP | 254,753 | 0.70% | $1.69M | – | 0.30% |
| Formula Growth Ltd | 240,088 | 0.66% | $1.60M | −1,050 | 0.56% |
| National Bank Of Canada /Fi/ | 218,698 | 0.60% | $1.25M | +1,523 | 0.00% |
| Thompson Davis & Co., Inc. | 216,535 | 0.59% | $1.44M | +750 | 0.86% |
| Dauntless Investment Group, LLC | 208,369 | 0.57% | $1.39M | −32,370 | 1.09% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 56 | 16M | 45.2% | 5 / 13 | 17 / 5 | 1M | 0M |
| Q1 2026 | 57 | 16M | 44.7% | 10 / 21 | 7 / 16 | 2M | 2M |
| Q4 2025 | 63 | 16M | 44.0% | 26 / 18 | 7 / 6 | 5M | 0M |
| Q3 2025 | 43 | 11M | 30.3% | 5 / 10 | 11 / 6 | 0M | 2M |
| Q2 2025 | 44 | 13M | 35.4% | 4 / 16 | 12 / 9 | 1M | 1M |
| Q1 2025 | 49 | 13M | 35.1% | 7 / 13 | 11 / 10 | 0M | 1M |
| Q4 2024 | 52 | 14M | 37.7% | 17 / 19 | 5 / 6 | 5M | 0M |
| Q3 2024 | 44 | 9M | 25.8% | 9 / 12 | 8 / 4 | 1M | 1M |
| Q2 2024 | 39 | 10M | 26.1% | 4 / 13 | 9 / 7 | 0M | 0M |
| Q1 2024 | 42 | 10M | 26.1% | 5 / 12 | 13 / 8 | 1M | 0M |
| Q4 2023 | 45 | 9M | 25.3% | 16 / 10 | 9 / 2 | 2M | 0M |
| Q3 2023 | 31 | 7M | 20.5% | 1 / 9 | 8 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PROF | Value | % of fund | As of |
|---|---|---|---|---|---|
| First Eagle Small Cap Opportunity Fund | 398,048 | 1.09% | $2.94M | 0.10% | Jul 31, 2026 |
| Royce Micro-Cap Fund | 343,903 | 0.94% | $1.61M | 0.53% | Jun 30, 2026 |
| Royce Capital Fund - Micro-Cap Portfolio | 112,878 | 0.31% | $529.19K | 0.53% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 22,878 | 0.06% | $155.80K | 0.00% | May 31, 2026 |
| The Canadian Small Company Series | 4,590 | 0.01% | $33.87K | 0.00% | Jul 31, 2026 |
| International Core Equity 2 Portfolio | 3,806 | 0.01% | $28.09K | 0.00% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 1,891 | 0.01% | $13.96K | 0.00% | Jul 31, 2026 |
| Dimensional International Small Cap ETF | 908 | 0.00% | $4.79K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Arun Swarup Menawat | CEO, Director | 587,089 | 1.61% | May 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Arun Swarup Menawat CEO, Director | May 16, 2025 | Buy | +12,027 | $4.73 | $56.89K | 587,089 |
| Arun Swarup Menawat CEO, Director | May 15, 2025 | Buy | +10,003 | $4.33 | $43.31K | 575,062 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Abbey Goodman Officer | Nov 12, 2024 | 13,014 | $105.54K | Nov 12, 2024 | RSU Vesting |
| Helen Jordan-Cornet Spouse | Sep 23, 2024 | 564 | $4.22K | Sep 18, 2024 | Open Market Purchase |
| Helen Jordan-Cornet Spouse | Sep 23, 2024 | 631 | $4.73K | Sep 23, 2024 | Open Market Purchase |
| Helen Jordan-Cornet Member of immediate family of any of the foregoing | Aug 30, 2024 | 22 | $219 | Aug 30, 2024 | OPEN MARKET PURCHASE |
| Helen Jordan-Cornet Member of immediate family of any of the foregoing | Aug 27, 2024 | 105 | $1.05K | Aug 27, 2024 | Open Market Purchase |
| Abbey Goodman Officer | Mar 26, 2024 | 8,692 | $70.06K | Mar 26, 2024 | Vested Restricted Stock Units |